Checkpoint Capital
Checkpoint Capital
Period
Q1 2026
Portfolio Date
Mar 31, 2026
Stocks Held
8
Market Value
$278.7M
Holdings Value Trend
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Top 5 Holdings
1
A
$ARGX
argenx SE
40.1%
% of Portfolio
Increased 7.75%
2R
$RYTM
Rhythm Pharmaceuticals, Inc.
38.3%
% of Portfolio
Increased 23.68%
3R
$RVMD
Revolution Medicines, Inc.
9.2%
% of Portfolio
Decreased 29.04%
4I
$IRON
Disc Medicine, Inc.
6.6%
% of Portfolio
Decreased 36.72%
5C
$CYTK
Cytokinetics, Incorporated
4.3%
% of Portfolio
Increased 7.90%
Historical Positions
| Symbol | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|
| ARGX | 40.1% | 37.3% | 37.1% | 38.5% |
| RYTM | 38.3% | 33.2% | 25.8% | 31.2% |
| RVMD | 9.2% | 9.2% | 7.7% | 4.8% |
| IRON | 6.6% | 11.2% | 9.5% | 6.5% |
| CYTK | 4.3% | 3.3% | 0.7% | - |
| SEPN | 0.9% | 0.0% | 1.8% | 2.9% |
| CRNX | 0.5% | 0.0% | 3.6% | - |
| TRVI | 0.2% | - | - | - |
Post-Filing Contributors
Price change since reported price, ranked by portfolio contribution
ARGX+22.19%
RVMD+62.23%
RYTM+10.19%
IRON+9.81%
Sector Analysis
Healthcare100.0%